APA (7th ed.) Citation

Feder, S., Haberl, E. M., Spirk, M., Weiss, T. S., Wiest, R., & Büchler, C. (2020). Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients. Clinical and Experimental Medicine, 20, 289-297. https://doi.org/10.1007/s10238-020-00617-4

Chicago Style (17th ed.) Citation

Feder, Susanne, Elisabeth M. Haberl, Marlen Spirk, Thomas S. Weiss, Reiner Wiest, and Christa Büchler. "Pentraxin-3 Is Not Related to Disease Severity in Cirrhosis and Hepatocellular Carcinoma Patients." Clinical and Experimental Medicine 20 (2020): 289-297. https://doi.org/10.1007/s10238-020-00617-4.

MLA (9th ed.) Citation

Feder, Susanne, et al. "Pentraxin-3 Is Not Related to Disease Severity in Cirrhosis and Hepatocellular Carcinoma Patients." Clinical and Experimental Medicine, vol. 20, 2020, pp. 289-297, https://doi.org/10.1007/s10238-020-00617-4.